Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
This study aims to explore the correlation between serum chloride levels and all-cause mortality among patients in the Surgical Intensive Care Unit (SICU).A retrospective cohort study was conducted using data extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, focusing on patients admitted to surgical/trauma ICUs. Data included demographic information, laboratory results, medical history, vital signs, and prognosis-related variables. Patients were categorized into four groups based on serum chloride levels. Outcome measures included 30-day, 90-day, and 180-day mortality rates post-ICU admission. Kaplan–Meier survival analysis curves, Cox proportional hazards regression analysis, and Restricted Cubic Spline (RCS) models were used to analyze the relationship between serum chloride levels and clinical outcomes.A total of 10,996 patients were included in the study. The 30-day mortality rate was 12.78%, the 90-day mortality rate was 17.14%, and the 180-day mortality rate was 20.32%. Kaplan-Meier survival analysis demonstrated significant differences in survival rates among different serum chloride level groups during the 30-day, 90-day, and 180-day follow-up periods (p < 0.001). Multivariate Cox regression analysis results indicated that elevated serum chloride levels were significantly associated with decreased all-cause mortality rates at 30-days (adjusted hazard ratio [aHR]: 0.96; 95% confidence interval [CI]: 0.94–0.98; P < 0.001), 90-days (aHR: 0.97; 95% CI: 0.96–0.98; P < 0.001), and 180-days (aHR: 0.97; 95% CI: 0.96–0.98; P < 0.001). Moreover, compared with the first quartile of serum chloride levels, the risk of death was significantly lower in the fourth quartile (30-days aHR = 0.65, 90-days aHR = 0.71, 180-days aHR = 0.69, P < 0.001).RCS curves showed an L-shaped relationship between serum chloride levels and all-cause mortality risk for SICU patients at 30-days, 90-days, and 180-days. Although the magnitude of reduction diminished when levels reached 104 mmol/L, an increase in serum chloride levels was associated with a decreased risk of mortality.This study demonstrates a significant nonlinear relationship between serum chloride levels and all-cause mortality rates among SICU patients. This finding contributes to a more precise monitoring of chloride levels in SICU patients.
This study aims to explore the correlation between serum chloride levels and all-cause mortality among patients in the Surgical Intensive Care Unit (SICU).A retrospective cohort study was conducted using data extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, focusing on patients admitted to surgical/trauma ICUs. Data included demographic information, laboratory results, medical history, vital signs, and prognosis-related variables. Patients were categorized into four groups based on serum chloride levels. Outcome measures included 30-day, 90-day, and 180-day mortality rates post-ICU admission. Kaplan–Meier survival analysis curves, Cox proportional hazards regression analysis, and Restricted Cubic Spline (RCS) models were used to analyze the relationship between serum chloride levels and clinical outcomes.A total of 10,996 patients were included in the study. The 30-day mortality rate was 12.78%, the 90-day mortality rate was 17.14%, and the 180-day mortality rate was 20.32%. Kaplan-Meier survival analysis demonstrated significant differences in survival rates among different serum chloride level groups during the 30-day, 90-day, and 180-day follow-up periods (p < 0.001). Multivariate Cox regression analysis results indicated that elevated serum chloride levels were significantly associated with decreased all-cause mortality rates at 30-days (adjusted hazard ratio [aHR]: 0.96; 95% confidence interval [CI]: 0.94–0.98; P < 0.001), 90-days (aHR: 0.97; 95% CI: 0.96–0.98; P < 0.001), and 180-days (aHR: 0.97; 95% CI: 0.96–0.98; P < 0.001). Moreover, compared with the first quartile of serum chloride levels, the risk of death was significantly lower in the fourth quartile (30-days aHR = 0.65, 90-days aHR = 0.71, 180-days aHR = 0.69, P < 0.001).RCS curves showed an L-shaped relationship between serum chloride levels and all-cause mortality risk for SICU patients at 30-days, 90-days, and 180-days. Although the magnitude of reduction diminished when levels reached 104 mmol/L, an increase in serum chloride levels was associated with a decreased risk of mortality.This study demonstrates a significant nonlinear relationship between serum chloride levels and all-cause mortality rates among SICU patients. This finding contributes to a more precise monitoring of chloride levels in SICU patients.
Fluids are drugs used in veterinary patients capable of producing beneficial therapeutic or inadvertent harmful effects within the body’s intravascular, interstitial, and intracellular fluid spaces. The individualized design of a fluid therapy plan requires careful patient assessment and targeted selection of proper fluid types, administration routes, and rates, along with adjustments during therapy tailored specifically as per the individual patient’s fluid requirement and therapeutic response. Personalized fluid prescriptions and vigilant patient monitoring help avoid patient morbidity from body fluid deficiencies, fluid excess, and electrolyte derangements and support better patient outcomes. These guidelines provide an overview of fluid dynamics within the fluid spaces of the body, describe various types of fluids and their uses, and outline recommendations for fluid administration for resuscitation, rehydration, and maintenance purposes. The guidelines also outline approaches to fluid therapy for anesthetized patients and reiterate the recommendations of reduced fluid rates in this population of patients. Additionally, the guidelines include practical fluid therapy strategies for patients with various common disorders. The goal of these guidelines is to help veterinary professionals safely and effectively prescribe and administer fluid therapy for canine and feline patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.